Canada markets closed

Takeda Pharmaceutical Company Limited (TKD.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
24.54+0.33 (+1.36%)
At close: 12:59PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in JPY. All numbers in thousands
Breakdown
ttm
2024-03-31
2023-03-31
2022-03-31
2021-03-31
Total Revenue
4,263,762,000
-
4,027,478,000
3,569,006,000
3,197,812,000
Cost of Revenue
1,426,678,000
-
1,244,072,000
1,106,846,000
994,308,000
Gross Profit
2,837,084,000
-
2,783,406,000
2,462,160,000
2,203,504,000
Operating Expenses
Research Development
729,924,000
-
633,325,000
526,087,000
455,833,000
Selling General and Administrative
1,053,819,000
-
997,309,000
886,361,000
875,663,000
Total Operating Expenses
2,623,008,000
-
2,230,300,000
1,928,585,000
1,805,437,000
Operating Income or Loss
214,076,000
-
553,106,000
533,575,000
398,067,000
Interest Expense
219,850,000
-
116,973,000
122,432,000
130,806,000
Total Other Income/Expenses Net
6,473,000
-
-42,374,000
-103,831,000
106,321,000
Income Before Tax
52,791,000
-
375,090,000
302,571,000
366,235,000
Income Tax Expense
-91,406,000
-
58,052,000
72,405,000
-9,936,000
Income from Continuing Operations
144,197,000
-
317,038,000
230,166,000
376,171,000
Net Income
144,067,000
-
317,017,000
230,059,000
376,005,000
Net Income available to common shareholders
144,067,000
-
317,017,000
230,059,000
376,005,000
Basic EPS
123.18
92.09
204.29
147.14
240.72
Diluted EPS
121.35
91.16
201.94
145.87
238.96
Basic Average Shares
1,557,376
1,564,450
1,551,809
1,563,501
1,562,006
Diluted Average Shares
1,576,431
1,580,343
1,569,872
1,577,169
1,573,537